Kevin Bray

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

Kevin Nishimoto, Taylor Barca, Aruna Azameera et al. · Clinical & Translational Immunology · 2022 · 100 citations · Full text

Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning

Lauric Haber, Kara Olson, Marcus P. Kelly et al. · Scientific Reports · 2021 · 93 citations · Full text

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

David J. DiLillo, Kara Olson, Katja Mohrs et al. · Blood Advances · 2021 · 52 citations · Full text

Cancer Immunosurveillance, Bcmaxcd3 Bsab, Bcmaxcd3 Bsab Administration +14

Spontaneous amplification of the ADH4 gene in Saccharomyces cerevisiae.

Michael J. Dorsey, Christopher Peterson, Kevin Bray et al. · Genetics · 1992 · 35 citations · Full text

REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells

David J. DiLillo, Kara Olson, Katja Mohrs et al. · Blood · 2018 · 16 citations